enGene
Kristine S. Louis possesses extensive experience in the biotechnology and molecular genetics fields, currently serving as Associate Scientist at enGene since November 2018. Prior roles include Research Associate II and Research Associate at the same company, as well as Biotech Analyst at SGS from October 2015 to October 2018, where collaboration with over 23 pharmaceutical companies led to significant method developments compliant with cGMP guidelines. Earlier experience includes contributions as a Regenerative Medicine Research Technician at University Health Network, where innovative preservation models for organs were developed, and as a Graduate Student at University of Toronto focusing on oncogene research. Kristine S. Louis holds a Master of Science in Molecular Genetics and an Honours Bachelor of Science in Cellular and Molecular Biology from the University of Toronto.
This person is not in any offices
enGene
enGene Inc. is a biotechnology company developing a proprietary non-viral gene therapy platform for localized delivery of nucleic acid payloads to mucosal tissues. The dually derived chitosan (DDX) platform has a high-degree of payload flexibility including DNA and various forms of RNA (siRNA, shRNA, lncRNA etc.) with broad tissue and disease applications